SRx Health CEO reports initial share holdings
SRx Health Solutions, Inc. Chief Executive Officer Kent Douglas Cunningham filed an initial Form 3 reporting his ownership in the company.
Rhea-AI Filing Summary
SRx Health Solutions, Inc. Chief Executive Officer Kent Douglas Cunningham filed an initial Form 3 reporting his ownership in the company. The filing lists 610,596 shares of common stock held directly, plus 44,464 common shares held indirectly through Halo Spin-Out SPV, Inc.
He also reports 63 shares of Series B Preferred Stock. In addition, he holds options covering 8,000 shares with a $5.0000 exercise price expiring on June 26, 2034, and Series B Warrants for 247,522 underlying shares with a $0.3182 exercise price expiring on March 16, 2029. This Form 3 records existing positions rather than new market transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
5 transactions reported
Mixed
5 txns
Insider
Cunningham Kent Douglas
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Options | -- | -- | -- |
| holding | Series B Warrants | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Series B Preferred Stock | -- | -- | -- |
Holdings After Transaction:
Options — 8,000 contracts (Direct);
Series B Warrants — 247,522 contracts (Direct);
Common Stock — 610,596 shares (Direct);
Common Stock — 44,464 shares (Indirect, Indirectly owned through ownership in Halo Spin-Out SPV, Inc.);
Series B Preferred Stock — 63 shares (Direct)
Key Figures
Direct common stock: 610,596 shares
Indirect common stock: 44,464 shares
Series B Preferred Stock: 63 shares
+2 more
5 metrics
Direct common stock
610,596 shares
Common Stock held directly as of Form 3
Indirect common stock
44,464 shares
Common Stock indirectly owned through Halo Spin-Out SPV, Inc.
Series B Preferred Stock
63 shares
Directly held preferred shares as reported
Stock options
8,000 underlying shares at $5.0000
Options expiring June 26, 2034
Series B Warrants
247,522 underlying shares at $0.3182
Warrants expiring March 16, 2029
Key Terms
Form 3, Series B Warrants, Series B Preferred Stock, indirectly owned, +1 more
5 terms
Form 3 regulatory
"filed an initial Form 3 reporting his ownership in the company"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
Series B Warrants financial
"Series B Warrants for 247,522 underlying shares with a $0.3182 exercise price"
Series B warrants are contracts issued alongside a company's Series B financing that give the holder the right to buy a set number of shares at a fixed price within a specified time. For investors, they matter because they can provide leveraged upside if the company grows, or they can dilute existing shareholders when exercised—like a coupon promising a future share at a known price that can add value or change ownership stakes.
Series B Preferred Stock financial
"He also reports 63 shares of Series B Preferred Stock"
Series B preferred stock is a type of ownership share issued by a company that offers certain advantages over common stock, such as priority in receiving dividends or assets if the company is sold or liquidated. It is typically issued after an initial round of funding, making it a way for investors to support a company's growth while gaining some protections and benefits. This stock matters to investors because it often provides a more secure investment position with potential for future growth.
indirectly owned financial
"44,464 common shares held indirectly through Halo Spin-Out SPV, Inc."
exercise price financial
"options covering 8,000 shares with a $5.0000 exercise price expiring"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does SRXH CEO Kent Douglas Cunningham report in this Form 3 filing?
He reports existing ownership stakes in SRx Health Solutions, Inc., not new trades. The filing shows common stock, Series B Preferred Stock, options and Series B Warrants, providing a snapshot of his initial equity and derivative positions as an executive.
What derivative securities in SRXH does the CEO report on Form 3?
He reports options and Series B Warrants linked to SRx Health stock. The options cover 8,000 underlying shares at a $5.0000 exercise price, while the Series B Warrants cover 247,522 shares at a $0.3182 exercise price, both with long-dated expirations.
What preferred stock position in SRXH is disclosed by the CEO?
The filing lists 63 shares of Series B Preferred Stock held directly by the CEO. This preferred position sits alongside his common stock, options and warrant holdings, indicating exposure across several layers of SRx Health’s capital structure.
Are there any buy or sell transactions in this SRXH Form 3 filing?
No, the Form 3 reflects holdings rather than new buy or sell activity. All entries are categorized as holdings, with transaction codes and directions marked as unknown, consistent with an initial statement of beneficial ownership for a reporting insider.
How are the CEO’s indirect SRXH holdings structured?
He reports 44,464 SRx Health common shares as indirectly owned through Halo Spin-Out SPV, Inc. This means the shares are held by that entity rather than directly in his name, but are still reported as part of his beneficial ownership position.
AI-generated analysis. How Rhea-AI works. Not financial advice.
